Method and apparatus for measuring absolute concentration values of constituents in tissue, blood flow and blood volume - Patents.com
Patent Information
- Application Number
- JP2024533321
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2021-08-11
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2041-08-11
AI Technical Summary
【0019】 本発明の更なる詳細は、添付の図面に示す本発明の好適実施形態の以下の説明から明らかになるであろう。本発明のさらなる利点もまた、本発明の目的が、特許請求の範囲内でどのように変更され、またはどのように発展され得るかについての示唆および提案とともに、詳細な説明から明らかとなる。
Smart Images

Figure 2024541689000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a method and apparatus for measurements in tissue, in particular to a method and apparatus for non-invasively determining absolute concentration values of constituents and / or blood flow and / or volume in organs using injectable indicators. [Background technology]
[0002] Known methods for determining concentration values of constituents, blood flow and blood volume in organs or organ tissues generally consist of non-invasive measurements, which does not exclude the injection of tracer substances.
[0003] However, known non-invasive measurement methods for determining the concentration of components in a measurement volume of an organ often do not allow the determination of absolute concentration values, but only detect relative concentration values, i.e. changes in the concentration value of one or more components. Near-infrared spectroscopy (NIRS) is such a non-invasive optical spectroscopic method, which is used, for example, in particular for the continuous monitoring of oxygen saturation in living tissues. NIRS is based on the principle that light in the near-infrared wavelength range penetrates living tissues and is absorbed and scattered differently by hemoglobin, myoglobin and / or other congeners in deoxygenated or oxygenated states, allowing the optical attenuation of the transmitted and / or scattered light compared to the light irradiated on the tissue to be detected by a sensor. With the appropriate algorithms and under certain assumptions, the concentration changes of tissue components, such as oxygenated or deoxygenated hemoglobin, can be calculated from the detected measurement signal. In general, the evaluation of the measurement signal of living tissues is based on a model that follows the diffusion equation and the Beer-Lambert law. Beer-Lambard's law describes the attenuation of the initial intensity of radiation as it passes through a medium containing an absorbing material as a function of the concentration and thickness of the absorbing material.
[0004] In contrast, non-invasive determination of absolute concentration values of components based on the modified Beer-Lambard law is difficult, and such values can only be approximated under simplifying assumptions. Generally, in NIRS measurements in living tissues, neither the actual absolute value of absorption nor the actual path length of the light path traveled per defined period is known. Therefore, absolute concentration values of chromophores cannot be determined with this model.
[0005] US Patent No. 6,456,862 describes the non-invasive measurement of blood oxygen saturation in tissue using a spectrophotometric sensor in the near infrared range, which allows the determination of absolute concentration values of oxyhemoglobin and deoxyhemoglobin. The sensor irradiates the tissue with optical signals of first, second and third wavelengths and detects the optical signals after passing through the tissue. The attenuation of the optical signal is described as the sum of the attenuation due to the deoxyhemoglobin and oxyhemoglobin components and scattering in the tissue. This method requires calibration of the sensor to the tissue of interest to account for attenuation due to optical scattering, attenuation due to absorption by solid tissue components such as bone and / or water, and / or attenuation due to changes in the sensor characteristics during the evaluation. Empirical data may be considered for the calibration, or arterial oxygen saturation may be determined using pulse oximetry as a reference sensor to determine venous oxygen saturation.
[0006] In addition to the relative concentration changes or absolute concentration values of components in organ tissues, blood flow and / or blood volume can be considered as diagnostic parameters that contain information about the blood perfusion and functionality of the target tissue. Near-infrared spectroscopy (NIRS) has also been used for a long time to determine these diagnostic parameters non-invasively. By measuring the concentration changes of components in organ tissues, NIRS allows to draw conclusions about the area of oxygen metabolism. The use of NIRS is known for monitoring cerebral blood flow (CBF) and cerebral oxygenation patterns, i.e. to measure the static and dynamic characteristics of cerebral blood and blood flow, respectively.
[0007] For the measurement and monitoring of cerebral blood flow, a method is known that combines non-invasive measurements with intravenous injection of a tracer substance. The tracer substance can be, for example, indocyanine green (ICG), which is mostly inert and whose distribution is mostly limited to the intravascular compartment. Indocyanine green has an absorption peak at about 805 nm and therefore belongs to the near-infrared spectrum. ICG binds very quickly and almost completely to serum albumin in the plasma, and in this state it has a very high near-infrared absorption and is absorbed by the liver, allowing rapid repeated measurements. ICG is used in various investigations of liver function and to calculate cardiac output from the recirculation time.
[0008] Starting from a bolus injection of indocyanine green, its absorption in the studied cerebral vasculature can be determined invasively and / or non-invasively, for example by NIRS. The measurement data can then be further processed, for example to determine cerebral blood flow.
[0009] US Patent No. 7,529,576 describes a device for measuring the blood flow and blood volume, in particular the cerebral blood flow (CBF), of an organ by means of an injected, almost inert indicator. The device uses sensors known per se to detect the part of the irradiated near-infrared radiation emerging from the organ tissue, which has a pulsatile and a non-pulsatile part. The evaluation algorithm calculates the blood volume in the organ as the quotient of the concentration from the non-pulsatile component associated with the organ tissue and the concentration from the pulsatile component of the injected indicator associated with the blood volume in the organ, taking into account the inflow function characterizing the organ perfusion. The value of the blood volume associated with the determined mean transit time allows the blood flow in the organ to be calculated. However, a drawback of this method is that, since the sensor is attached to a surface, the effect of layers located between the measurement volume and the inlet and / or outlet of the measurement signal distorts and weakens the measurement signal, which effect is not taken into account in the evaluation.
[0010] US Patent No. 6,223,069 describes a method for measuring cerebral blood flow and blood flow in extracerebral organs, in which measurements of the flow rate of an intravenously injected bolus of a tracer substance with absorption properties in the near-infrared spectrum are performed simultaneously in both cerebral hemispheres using near-infrared spectroscopy and in the arterial blood of the systemic circulation using pulse densiometric arterial chromometry. The evaluation algorithm developed to evaluate the measurements is based on the deconvolution of arterial and cerebral flow kinetics and calculates the transcerebral transport function. From these kinetics, a blood flow index can be determined that is directly proportional to the cerebral blood flow.
[0011] Previously known methods and devices for non-invasively measuring blood flow, in particular blood volume and / or absolute concentration values of components in tissues or organs using injected indicators are often technically difficult to implement and time-consuming. In addition to the inaccuracies caused by the adoption of simplifying assumptions for the evaluation of the measurement data of conventional NIRS measurements about the behavior of the injected indicators at the first onset of the input signal, further problems arise from the non-constant measurement background with changing absorption characteristics.
[0012] Up to now, in simplified interpretation of the measured data, it has often been assumed that no changes in the background absorption occur during the NIRS measurement. With this assumption, the differential absorption is calculated from a modified relation of the Beer-Lambard law. Assuming the idealized background constancy, the background influence due to the shape and composition of the tissue, absorption behavior, etc. is summarized in the coefficient G. However, in real systems and conditions, the background absorption is not constant. In particular, the water concentration of the brain measurement volume and the intracranial pressure are not constant, which leads to inaccuracies in the evaluation of the NIRS measurement signal and in the determination of concentration values in brain tissue, blood volume, and blood flow. Summary of the Invention [Problem to be solved by the invention]
[0013] In view of the shortcomings of previously known methods and devices, it would be desirable to provide a method and device for determining absolute concentration values of constituents in tissue, and more particularly, in brain tissue, as well as blood flow, and more particularly cerebral blood flow and blood volume, with greater accuracy than previously possible.
[0014] It would further be desirable to provide a method and device for evaluating a detectable measurement signal. Preferably, such a device can be used or performed non-invasively and can be combined with an indicator injection with reasonable technical effort. Furthermore, such a device can be used to perform invasive measurements, for example with a sensor unit or optode placed under the body surface. [Means for solving the problem]
[0015] According to the present invention, a method and apparatus are provided which is expected to substantially eliminate the influence of background and background absorption changes by taking into account the fluctuations in background and tissue water concentration when determining the absolute concentration values of tissue constituents. In this way, changes in measurement conditions can be verified, and the measurement results are more accurate and meaningful.
[0016] Similarly, the influence of employing an indicator is reduced when determining blood flow and blood volume. Whereas in previously known systems the determination of blood flow and / or blood volume by application of an indicator assumed that the indicator bolus had the shape of a rectangular pulse, the method and device of the present invention avoids such a simplifying assumption. In particular, due to dispersion effects, pulsation, and other factors to be considered, a rectangular shape does not exist in reality, and the simplifying assumption leads to a distorted quantification. In reality, the increase in indicator concentration in the considered volume takes the form of a fuzzy peak. According to the principles of the present invention, the influence of the actual increase in indicator concentration on the accuracy of the obtained measurement result can be almost eliminated.
[0017] According to the present invention, a method and an apparatus are provided for determining absolute concentration values, blood flow and / or blood volume of a component in tissue of an organ. In one embodiment, a sensor emits radiation having at least one wavelength in the near infrared spectrum into the tissue of the organ. The emerged radiation is detected by the sensor and a measurement signal is generated using near infrared spectroscopy. The measurement signal responsive to the detected intensity of the emerged radiation from the tissue is input to a programmable evaluation algorithm in a programmed evaluation unit, which calculates the time change of the detected intensity of the emerged radiation and calculates the absolute concentration value of the component by using a system matrix.
[0018] According to one embodiment, an indicator having an absorption peak in the near infrared spectrum is introduced during the acquisition of near infrared spectroscopy data, and the time course of concentration values of the indicator in the organ tissue is determined. A mean transit time mtt is derived from the time course of the concentration values of the indicator, and the blood volume is determined from the time course of the concentration values of the indicator or a parameter derived therefrom using at least one transport function g(t) characterizing the blood flow in the organ tissue.
[0019] Further details of the invention will become apparent from the following description of preferred embodiments of the invention, which are illustrated in the accompanying drawings. Further advantages of the invention will also become apparent from the detailed description, together with suggestions and suggestions as to how the object of the invention can be modified or developed within the scope of the claims. [Brief description of the drawings]
[0020] [Figure 1] FIG. 1 is a schematic diagram of an apparatus according to the invention for determining absolute concentration values and / or blood flow in a tissue of interest, for example brain tissue. [Diagram 2] FIG. 2 is a schematic diagram of a programmed evaluation unit suitable for implementing the algorithm of the invention. [Diagram 3] FIG. 3 is a schematic diagram of a method according to the invention implemented as a program in an evaluation unit for determining cerebral blood flow from an input signal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0021] According to the principles of the invention, absolute values of physiological components can be calculated using a sensor that emits radiation at wavelengths in the near infrared spectrum and detects the emerging radiation to generate a measurement signal using near infrared spectroscopy. During near infrared spectroscopy, a bolus of indicator is introduced into the blood vessel and can be used to iteratively determine the inflow and outflow functions using a programmed evaluation unit. The indicator can be a dye and is introduced into the vascular system using an indicator injection device, such as a syringe or injection device, which is known per se.
[0022] More specifically, the concentration of the indicator bolus in the considered volume may be described by an inflow function and an outflow function. As these functions are not known or measurable, certain assumptions are made to allow their iterative determination. To this end, according to the invention, a programmable evaluation algorithm is provided which takes into account the outflow of the injected indicator from the considered area or volume during the onset of the measurement signal.
[0023] The method according to the invention for determining absolute concentration values of components and / or blood flow and / or blood volume in tissue of an organ comprises, inter alia: - irradiating the tissue with radiation having at least one wavelength in the near infrared spectrum and detecting the intensity of the emerging radiation by near infrared spectroscopy as a measurement signal responsive to the detected intensity of the radiation emerging from the tissue; - converting the time-dependent changes in the detection intensity of the radiation emerging from the tissue of the organ into absolute concentration values of the components using a system matrix and an evaluation algorithm implemented by a program in the evaluation unit; applying an indicator consisting of a dye having an absorption peak in the near infrared spectrum during near infrared spectroscopy and determining the concentration value of the indicator in the tissue over time; deriving a mean transit time mtt from the time course of the concentration values of the indicator using at least one transport function g(t) characterizing the blood flow in the tissue; calculating blood flow and / or blood volume from the time course of concentration values of the indicator and / or derived parameter; has.
[0024] In one embodiment of the method of the present invention, the system matrix can be first calibrated with known values of the concentration of the component in tissue, such as blood, background, and / or water, obtained from in vivo measurements of healthy patients or healthy tissue, and / or boundary conditions defined to constrain the concentration values of the component in tissue.
[0025] According to one embodiment of the method according to the invention, the method is arranged to determine from the intensity of the applied radiation and the intensity of the detected radiation, in particular from the measurement signals, absolute concentration values of at least one of the components comprising hemoglobin, deoxyhemoglobin, water, background and / or indicator, as well as the blood volume and / or blood flow rate in the tissue of the organ.
[0026] In particular, radiation of at least one wavelength in the near infrared spectrum, more preferably radiation of at least four wavelengths, is applied into the tissue of the organ at a first location. A measurement signal is detected by a sensor arranged at a second location spaced from the first location, which is representative of the applied and detectable radiation intensity or of a component of the applied radiation. Preferably, each of the at least four wavelengths may be selected such that each of the detected components has a local absorption peak or that the absorption of all components is at least as uniform as possible. The detected measurement signal can be transmitted as an input signal to a programmed evaluation unit, for example one or more processors which programmatically execute an evaluation algorithm having the following steps: a) obtaining a measurement signal based on the applied and detected portions of radiation having at least one wavelength in the near infrared spectrum, which is transmitted to an evaluation unit; b) determining absolute concentration values of at least hemoglobin, deoxyhemoglobin, background, and / or water components in the tissue of the organ; c) determining the time course of the concentration of the injected indicator in the tissue of the organ from the measurement signals; d) iteratively determining the inflow function i(t) and the outflow function o(t) characterizing the blood flow in the tissue of the organ, using a transport function g(t) with a determinable mean transit time mtt, until a termination criterion is reached; e) fitting the iteratively determined inflow function i(t) and the iteratively determined outflow function o(t) using a log-normal function or another type of function representing the tissue transit system; f) calculating the blood volume in the tissue of the organ using either the time function curve determined in step c) or e); g) calculating the blood flow in the organ as the quotient of the blood volume in the organ tissue calculated in step f) and the mean transit time mtt determined in step d); has.
[0027] Based on the detectable near infrared radiation emerging from the organ tissue, i.e., the detected intensity signal, an optical density (OD) value can be determined. In general, optical density or extinction is a measure of the attenuation of radiation when passing through a medium due to absorption, scattering, diffraction, and / or reflection. The optical density value can be determined as the negative logarithm of the transmittance as a function of the radiation wavelength.
[0028] The absolute concentration values of the components of the organ tissue and the background associated with the measurement volume can be determined using a preferably calibratable system matrix. The system matrix describes the imaging properties of NIR spectroscopy, taking into account the optical path lengths at different wavelengths, the extinction coefficients of the components considered and the molecular weights of the individual components (e.g. hemoglobin and water, etc.). The system matrix can be used for the solution of simultaneous equations so that the absolute concentration values of the components can be determined from the detected measurement signals.
[0029] According to an embodiment, for the preferably one-time calibration of the system matrix, the background of the tissue of the organ to be considered can be taken into account. The background may consist of several components, for example tissue, fat, bone, etc., in several combinations thereof, for each of which an extinction coefficient is used as a specific material constant. More generally, the extinction coefficient depends on the wavelength of the emitted radiation and on the temperature during the measurement. The extinction coefficients of the components of the background can be obtained from clinical data and / or literature for known concentration values, such as blood, hemoglobin and / or water, proportional to the expected presence of such components in the background. With the extinction coefficients known per se, a calibration of the NIR spectroscopy or the system matrix can be performed. Calibration is therefore an essential part of the evaluation algorithm for determining absolute concentration values of the components of the organ tissue.
[0030] In addition to the absorption properties of the inhomogeneous background, the optical density of the considered tissue, e.g. the optical density of the cerebrum, is taken into account when setting up the system matrix. The solution space of the system matrix can be restricted by a definable relationship between the determined optical density of the tissue at different wavelengths and a weighted sum of the concentration values of the components.
[0031] Using the detectable time-varying optical density, absolute concentration values of components in organ tissues can be calculated using the system matrix.
[0032] According to one aspect of the invention, the method can include determining the blood volume and / or blood flow rate using indocyanine green as an injectable indicator. However, the use of this indicator is not limited. In such an embodiment, the concentration of the injected indicator in the organ tissue of interest depends on the concentration at which the injected indicator enters the organ tissue with the inflowing blood and on the blood volume flowing through the organ tissue. The concentration of the injected indicator in the organ tissue varies due to distribution kinetics and degradation, so that the blood leaving the organ tissue has a different indicator concentration or concentration time course than the inflowing blood. After administration of the indicator, for example in the form of an indicator bolus, the indicator reaches the examined tissue by the blood flow after a certain time, the so-called transit time mtt, and is perfused into the existing capillary network or vasculature. From the determinable concentration-time curve of the injected indicator, the distribution volume of the same indicator and also the blood volume and / or blood flow rate in the tissue of the examined organ can be determined, which allows taking into account real effects in the evaluation.
[0033] According to an embodiment of the method, the blood flow in the tissue can be determined from the time course of determinable concentration values of the indicator in an organ or in the tissue of an organ. For this purpose, an inflow function i(t) and an outflow function o(t) can be determined iteratively. The inflow function i(t) describes the proportion of the concentration change of the injected indicator in the measurement volume under consideration, for example in brain tissue, that is caused by the inflowing blood volume. The outflow function o(t) describes the proportion of the concentration change of the indicator in the measurement volume that is caused by the outflowing blood volume.
[0034] In the iterative determination, each step involves approximation of an inflow function i(t) that can be expressed as a function of the time course cICG(t) of the concentration of the indicator in the tissue of the organ and an outflow function o(t).
[0035]
number
[0036] The outflow function o(t) can be determined by deconvolving the convolution integral of the inflow function i(t) and the transport function g(t) with * as the convolution operator.
[0037]
number
[0038] As a starting parameter for the iterations for the determination of the inflow function i(t), an estimated or determinable mean transit time mtt is selected, also called the turnaround time. The initial value of the mean transit time mtt can be determined by fitting and integrating the time course of the concentration values of the injected indicator cICG(t) with a log-normal distribution or other type of function describing the tissue transit system, i.e., the transit behavior of the blood flow through the tissue.
[0039] During the iterative determination of the inflow function i(t) and the outflow function o(t), the time variable t is set to zero for the time of indicator increase in the measurement volume. Furthermore, the inflow function i(t) and the outflow function o(t) are set to zero for t<0 to ensure a causal relationship between the time of indicator application and the measurable indicator increase.
[0040] The inflow function i(t) and outflow function o(t) are determined for an assumed mean transit time mtt using a transport function g(t). The time course of the transport function g(t) is generally a single-peaked asymmetric distribution and can be approximately described, for example, by a log-normal function. Here, the mean transit time mtt and the resulting transport function g(t) and the associated inflow function i(t) and outflow function o(t) are allowed to vary until a termination criterion to be determined is reached.
[0041] The inflow function i(t) at a certain time t can be expressed from the time course cICG(t) of the concentration value of an indicator, for example, indocyanine green ICG, and the outflow function o(t) according to a balance equation as follows:
[0042]
number
[0043] For the calculation of the influx function i(t), first, from the determinable time course of the optical density OD(t) of the indicator component indocyanine green, the extinction coefficient εICG, and the optical path length β of the covered light, the concentration cICG(t) of the indicator in the considered tissue is determined according to:
[0044]
number
[0045] The outflow function o(t) at time t can be formulated as the convolution integral of the inflow function i(t) and the transport function g(t). That is, deconvolution of the convolution integral can be used to determine the inflow function i(t) and / or the outflow function o(t), where T is a small constant time interval, or increment.
[0046]
number
[0047] The transport function g(t) can be formulated as a function of the transit time mtt according to one of the approaches known per se. A suitable approach is the log-normal function.
[0048]
number
[0049] Here, σ is a constant shape parameter whose value is a real number greater than 0. The shape parameter σ can be determined empirically, and σ roughly represents the width of the expected residence time distribution. As the value of σ decreases, the symmetry of the log-normal distribution increases.
[0050] In a subsequent step, a deconvolution of the established convolution integrals is performed to determine the inflow function i(t) and the outflow function o(t) based on the determinable time course cICG(t) of the concentration of the indicator, where the influence of recirculation on the time evolution of the concentration of the indicator cICG(t) in the considered measurement volume, and therefore also on the inflow function i(t) and the outflow function o(t), is removed by fitting a log-normal function.
[0051] In a subsequent step, it can be checked whether the previously determined function curves of the inflow function i(t) and the outflow function o(t) are plausible. Thus, the termination criterion for determining the mean transit time mtt can be defined by a plausibility criterion related to the inflow function i(t) and the outflow function o(t).
[0052] In one embodiment, the plausibility criterion may be defined by the distance from the center of gravity of the inflow function i(t) to the center of gravity of the outflow function o(t), which corresponds approximately to the mean transit time mtt.
[0053] Alternatively, the plausibility criterion can be defined by the ratio of the area under the inflow function i(t) to the area under the outflow function o(t). For example, the ratio can be 1:1.
[0054] If the function curves of the inflow function i(t) and the outflow function o(t) satisfy one of the plausibility criteria, i.e. if a termination criterion is reached, the variation of the transit time mtt is terminated and the procedure continues for determining the blood volume and / or blood flow in the organ tissue under consideration using the determined function curves of the inflow function i(t), the outflow function o(t) and the determined mean transit time mtt. If the function curves of the inflow function i(t) and the outflow function o(t) do not satisfy any of the plausibility criteria, it is possible to carry out again an iteration according to the above-mentioned steps, increasing or decreasing the mean transit time mtt by an increment τ and starting with the corresponding modified mean transit time mtt as a starting parameter.
[0055] According to one aspect of the method, the blood volume in an organ tissue can be determined by the area under the inflow function i(t) and outflow function o(t) based on the assumption that the area is proportional to the blood volume BV, e.g., the cerebral blood volume CBV, where the integration limits for the area determination can be selected according to the width of the curves of i(t) and o(t).
[0056] Instead of determining the blood volume using the integrals of the inflow function i(t) and outflow function o(t) to determine the corresponding area, the time course of the indicator concentration values cICG(t) can be used. The time course of the indicator concentration values cICG(t) can be approximately described by an exponential function using regression in the time interval t1>0 up to a final value t2>t1. This exponential function can be extrapolated to a certain time, for example t=0, i.e. the time of indicator injection.
[0057] Thus, from the determined time course of the indicator concentration values cICG(t), the calculation of the indicator concentration cTissue in the considered organ tissue immediately after injection can be determined by the following formula:
[0058]
number
[0059] The blood volume BV of an organ, for example the cerebral blood volume CBV, is calculated as the quotient of the indicator concentration associated with the considered tissue, cTissue, the known indicator concentration in blood, cBlood, and the tissue density ρTissue according to:
[0060]
number
[0061] The concentration of the indicator in the blood can be calculated from the total blood volume BV and the amount of indicator injected.
[0062] The blood flow BF in the organ considered can be determined as the quotient of the blood volume BV, for example the cerebral blood flow CBF, and the mean transit time mtt according to the following formula:
[0063]
number
[0064] As explained below, the invention includes an apparatus provided and / or programmed to carry out the method. In a preferred embodiment, the apparatus comprises an evaluation unit arranged by a program to execute an evaluation algorithm, a unit including electrical and / or optical components, and at least one sensor arrangement for providing radiation having at least one wavelength in the near infrared spectrum. The sensor unit comprises an optical component having at least one detector for detecting an exiting portion of the applied radiation.
[0065] Referring now to Fig. 1, a device 1 for determining absolute concentration values and / or for determining blood volume and / or blood flow rate in brain tissue is described. For this purpose, the device 1 includes a non-invasive measurement device and method combined with an indicator application. The sensor arrangement 10 is removably attached to the body surface of a patient. Alternatively, the sensor arrangement 10 can be inserted through the body surface of a patient to invasively determine absolute concentration values.
[0066] The sensor arrangement 10 is composed of electrical and optical components, for example combined in a unit 20, at least one sensor unit 30 for irradiating radiation having at least one wavelength in the near infrared spectrum, and at least one detector unit 40 for detecting radiation emerging from the body tissue. The radiation is preferably emitted into the body tissue at several different wavelengths in the near infrared spectrum from an external light source or from a light source arranged directly in the unit 20 or in the sensor unit 30, such as several light or laser diodes. At least one wavelength of the irradiated radiation is adapted to the injected indicator, for example indocyanine green ICG. If indocyanine green ICG is injected as indicator, one of the wavelengths may be in the range of 780-900 nm, preferably about 808 nm. To determine the optical concentration of several components in the measurement volume, it is desirable to use at least four wavelengths.
[0067] The sensor arrangement 10 consists of at least one detector unit 40, preferably a first and a second detector unit (not shown), which are arranged at an optimized distance from each other, where optimization is understood as regarding the penetration depth of the irradiated radiation into the body tissue and / or the signal-to-noise ratio.
[0068] The first and second detector units (not shown) are configured to detect a portion of the radiation emerging from the tissue as a measurement signal, which is transmitted to the evaluation unit 50. The transmission of the measurement signal may be performed in real time by cable or wirelessly. The evaluation unit 50 may consist of electronic equipment, for example one or more processors, and / or a light source, preferably programmed to execute a program. The one or more processors can communicate with each other via a wired bus or wirelessly. In case of wireless communication, remote access is possible at any time.
[0069] 2, an exemplary embodiment of an assessment unit 50 will be described. The assessment unit 50 comprises a computer, e.g., a laptop, desktop, or tablet, programmed with the assessment algorithm software described herein, and includes at least one processor 100, memory 110, non-volatile storage 120, optional transceiver 130, power supply 140, and one or more input devices 150 and output devices 160.
[0070] Processor 100 may be a conventional multi-core processor, such as an Intel CORE i5 or i7 processor. Memory 110 may be comprised of volatile memory (e.g., random access memory (RAM)), non-volatile memory (e.g., read-only memory (ROM)), flash memory, or any combination thereof.
[0071] The optional transceiver 130 can receive and / or transmit non-invasive measurement information to and from other components in the system, such as a remote monitoring station and / or a controller for injecting an indicator dye, using any well-known communications facility that facilitates communication over a wired or wireless connection, such as any IEEE 802 standard. The power source 140 preferably connects to a standard outlet and / or may include a battery. The non-volatile memory device 120 preferably includes removable and / or non-removable storage devices, such as solid state disk memory or a magnetic hard drive.
[0072] The input device 150 may be one or more devices coupled to or integrated into the evaluation unit 50 for inputting data into the evaluation unit and may include, for example, a keyboard or touch screen, a mouse and / or a pen. The input device 150 may be used to input data used in populating the system matrix, as well as patient-specific information, such as height, age, complexion, sex, and identity, into the evaluation unit. The output device 160 may be any suitable device coupled to or integrated into the evaluation unit 50 for outputting or otherwise displaying data, such as a video screen, printer, or plotter. The output device 160 may further include a speaker or alarm bell that may be activated if one or more measurement signals fall below a clinically significant threshold indicating patient distress.
[0073] 2, operating system 170 and evaluation algorithms 180 are stored in non-volatile storage 120. Operating system 170 includes an operating system for the evaluation unit, such as Microsoft Windows or Linux, and the necessary drivers for input and output devices.
[0074] The evaluation algorithm 180 may be personalized for a particular patient based on input provided through the input device 150 or may include machine learning and search algorithms to analyze the inputted patient-specific data to modify the data in the system matrix 190 to generate real-time extinction values appropriate for the patient being monitored. The evaluation algorithm 180 may also include programming for communicating and adjusting the input sampling rate of the input received from the sensor arrangement 10, and for generating an output that is displayed on the output device 160.
[0075] The evaluation algorithm 180 includes programmed instructions for generating absolute values of blood volume and blood flow, in particular cerebral blood volume and blood flow, using non-invasive measurement signals obtained from the sensor arrangement 10 as described herein. In particular, the evaluation algorithm may employ an iterative process for determining absolute concentration values of certain blood components, e.g., oxyhemoglobin and deoxyhemoglobin, blood flow and / or blood volume of tissues of an organ, using non-invasively measured patient physiological data, as described in the flow chart of FIG.
[0076] With reference to FIG. 3, an exemplary flow chart corresponding to a programmed evaluation algorithm 180 stored in the non-volatile memory device 120 of the evaluation unit 50 will be described.
[0077] The sensor arrangement 10 shown in FIG. 1 allows to carry out extinction measurements with high resolution, for example above 5 Hz, in step 200, for example on the patient's head. The time course of the optical density OD(t) for preferably several components in the considered measurement volume can thus be determined as the negative common logarithm of the quotient of the intensity of the detected near-infrared radiation and the intensity of the irradiated near-infrared radiation. Here, the optical density of the considered tissue can be determined for at least the components hemoglobin, deoxyhemoglobin, water, background and / or indicator. In step 210, a system matrix can be generated, which is preferably calibratable. For this purpose, the components of the background of the measurement volume and their proportions, as well as the influence of the background components on the extinction coefficient, are taken into account. Thus, taking into account the density of the organ, as well as using literature values and / or comparative measurements, absolute concentration values of the components in the considered measurement volume can be determined in step 220, in particular hemoglobin, deoxyhemoglobin, background and / or water, as well as the injected indicator, as shown in step 230. Such determined values may also be adjusted for patient specific values, for example, to adjust bone density based on age, to account for skin tone, etc.
[0078] In step 240, the evaluation algorithm subjects the indicator concentration change over time cICG(t) determined in step 230 to a plausibility check. If this evaluation fails, the measurement is considered invalid. In step 250, the indicator concentration time course cICG(t) is fitted with a log-normal function. In step 260, the mean transit time mtt is estimated, which is limited to a definable limit, i.e. the minimum transit time mtt min and maximum transit time (mtt) max and thus in a determinable range between mtt and t, and thus in a definable search interval. The search interval is defined in step 270. A query as to whether the mean transit time mtt is within the defined range can be made in step 280. The mean transit time mtt is determined for the iterative determination of the inflow function i(t) and the outflow function o(t) and for the determination of the blood volume and / or blood flow in the organ under consideration. The outflow function o(t) can be determined from the convolution integral of the inflow function i(t) and the transport function g(t), in particular the ascending branch of the curve can be approximately determined with a log-normal function as a function of the mean transit time mtt.
[0079] In step 290, a corresponding transport function g(t) is determined based on the minimum transit time mtt. In step 300, the time course of the inflow function i(t) and the time course of the outflow function o(t) can then be determined. The time course of the inflow function i(t) and the time course of the outflow function o(t) can be approximately described using corresponding log-normal distributions, as shown in step 310. In step 320, a plausibility check is performed using a plausibility criterion that defines a termination criterion for the variation of the mean transit time mtt.
[0080] As a first plausibility criterion, i.e. as an end criterion for the variation of the mean transit time mtt, the positions of the centroids of the inflow function i(t) and the outflow function o(t) can be determined, which have a definable distance from each other according to the first plausibility criterion. The definable distance can correspond to the mean transit time mtt.
[0081] Alternatively, a further or second plausibility criterion can be used, based on the area determined under the inflow function i(t) and the area determined under the outflow function o(t). If the second plausibility criterion is met, the areas to be determined are in a definable ratio to each other. Preferably, this ratio is 1:1.
[0082] If none of the above plausibility criteria are met, the mean transit time mtt can be varied in step 330 by increasing it by one increment, for example 0.5. This increase is continued until any of the plausibility criteria are met and other steps of the algorithm are executed. Otherwise, if a defined maximum allowable value for mtt is reached in step 270, such increase is stopped in step 280. In this case, mtt cannot be determined and the measurement is considered invalid.
[0083] In step 340, the blood volume BV and blood flow rate BF are determined based on the determined mean transit time mtt. To determine the blood volume, the time characteristic of the concentration value of the indicator cICG(t) can be approximately described by an exponential function in the time interval t1>0 to t2>t1, which can then be extrapolated to time t=0. Furthermore, the blood volume in the organ tissue under consideration can be considered proportional to the area under the inflow function i(t) and the outflow function o(t), which can be calculated by integration.
[0084] It should be understood that the embodiments described herein are exemplary, and that the components can be arranged, substituted, combined, and designed in a wide variety of different configurations, all of which are intended to be within the scope of the present disclosure. Accordingly, the foregoing description of exemplary embodiments has been presented for purposes of illustration and description, and is not intended to be exhaustive. Rather, it is intended that the scope of the present invention be defined by the claims. [Prior art documents] [Patent documents]
[0085] [Patent Document 1] U.S. Patent No. 6,456,862 [Patent Document 2] U.S. Patent No. 7,529,576 [Patent Document 3] U.S. Patent No. 6,223,069
Claims
1. 1. A method for determining an absolute concentration value of a component, blood flow, or blood volume in tissue of an organ, comprising: irradiating the tissue with radiation having at least one wavelength in the near infrared spectrum and generating a measurement signal responsive to a detected intensity of radiation emerging from the tissue by near infrared spectroscopy; - converting the time variation of the detected intensity of the radiation emerging from the tissue into absolute concentration values of constituents using a system matrix and an evaluation algorithm implemented in an evaluation unit; introducing an indicator comprising a dye having an absorption peak in the near infrared spectrum and determining a concentration value of the indicator in the tissue over time; deriving a mean transit time mtt from the concentration values of the indicator over time using at least one transport function g(t) characterizing blood flow in the tissue; calculating blood flow and / or blood volume from the concentration values of the indicator over time and / or from parameters derived therefrom; A method for providing the above.
2. 2. The method of claim 1, wherein the system matrix is calibrated using known concentration values of the component in the tissue, measurable concentration values of the component in healthy tissue, or definable boundary conditions for constraining the concentration values of the component in the tissue.
3. 2. The method of claim 1, wherein the measurement signal corresponds to an absolute concentration value of one or more of hemoglobin, deoxyhemoglobin, water, background, or the indicator, allowing a determination of the blood volume or blood flow in the tissue.
4. The evaluation algorithm comprises: a) accepting the measurement signal based on the applied and detected portion of the applied radiation having at least one wavelength in the near infrared spectrum as a measurement signal to be transmitted to the evaluation unit; b) determining absolute concentration values of at least hemoglobin, deoxyhemoglobin, background, or water components in the tissue; c) determining from the measurement signals the concentration of the indicator in the tissue over time; d) iteratively determining inflow and outflow functions i(t) and o(t) indicative of blood flow in said tissue using a transport function g(t) having said determinable mean transit time mtt until a termination criterion is reached; e) fitting the iteratively determined inflow function i(t) and the iteratively determined outflow function o(t) with a log-normal function or another function representing the tissue passage system; f) calculating the blood volume in the tissue using either the function determined in step c) or e); g) calculating the blood flow rate in the tissue as the quotient of the blood volume calculated in step f) and the mean transit time mtt determined in step d).
2. The method of claim 1, wherein the method is programmed to:
5. 5. The method of claim 4, wherein in step f) the blood volume in the tissue can be determined using an exponential regression analysis of the time course of the concentration of the indicator.
6. 5. The method of claim 4, wherein in step f) the blood volume in the tissue is determined from the areas under the inflow function i(t) and the outflow function o(t).
7. The iterative determination of the inflow function i(t) comprises a number of steps, in each step an approximation of the inflow function i(t) is calculated according to the following formula: [0089] where d / dt(cICG(t)) is the determinable time change in the concentration of the indicator in the tissue, and o(t) is the efflux function determinable from the deconvolution of the convolution integral of the inflow function i(t) and the transport function g(t): ##EQU00011## 5. The method of claim 4.
8. 5. The method of claim 4, wherein the termination criterion for determining the mean transit time mtt is defined by a plausibility criterion for the inflow function i(t) and the outflow function o(t).
9. 9. The method of claim 8, wherein the plausibility criterion can be defined as the distance between the center of gravity of the inflow function i(t) and the center of gravity of the outflow function o(t) and corresponds to the determinable mean transit time mtt.
10. 9. The method of claim 8, wherein the plausibility criterion is definable as the ratio of the area under the inflow function i(t) to the area under the outflow function o(t).
11. 11. The method of claim 10, wherein the ratio is 1:
1.
12. 1. An apparatus for determining absolute concentration values of a component, blood flow, or blood volume in tissue of an organ in conjunction with an indicator introduced into the tissue via an injection device, the indicator comprising a dye having an absorption peak in the near infrared spectrum, the apparatus comprising: a sensor arrangement configured to irradiate the tissue with radiation having at least one wavelength in the near infrared spectrum and to generate, by near infrared spectroscopy, a measurement signal responsive to a detected intensity of radiation emerging from the tissue; An evaluation unit having a processor and a memory for storing a system matrix, said evaluation unit comprising: converting the change in the detected intensity of the radiation emerging from the tissue over time into absolute concentration values of components using a system matrix; determining a time course of concentration values of the indicator in the tissue; deriving a mean transit time mtt from the time course of concentration values of the indicator using at least one transport function g(t) characterizing blood flow in the tissue; Calculating blood flow or blood volume from the time course of concentration values of the indicator or a parameter derived therefrom. an evaluation unit programmed to execute an evaluation algorithm; An apparatus comprising:
13. 13. The apparatus of claim 12, wherein the system matrix is calibrated using known concentration values of the component in the tissue, measurable concentration values of the component in healthy tissue, or definable boundary conditions for limiting the concentration values of the component in the tissue.
14. 13. The device according to claim 12, characterized in that the measurement signal corresponds to one or more absolute concentration values of hemoglobin, deoxyhemoglobin, water, background or the indicator, and the evaluation algorithm enables the determination of the blood volume or the blood flow in the tissue.
15. The evaluation unit further comprises: a) receiving a measurement signal based on an illuminated and detected portion of the illuminated radiation having at least one wavelength in the near infrared spectrum; b) determining absolute concentration values of at least hemoglobin, deoxyhemoglobin, background, or water components in said tissue; c) determining from the measurement signals the concentration of the indicator in the tissue over time; d) iteratively determining inflow and outflow functions i(t) indicative of blood flow in said tissue using a transport function g(t) having a determinable mean transit time mtt until a termination criterion is reached; e) fitting the iteratively determined inflow function i(t) and the iteratively determined outflow function o(t) with a lognormal function; f) calculating the blood volume in the tissue using either the function determined in step c) or e); g) calculating the blood flow in the tissue as the quotient of the blood volume calculated in step f) and the mean transit time mtt determined in step d).
13. The apparatus of claim 12, wherein the apparatus is programmed to:
16. 16. The apparatus of claim 15, wherein the evaluation unit is further programmed in step f) to determine the blood volume in the tissue using an exponential regression analysis of the time course of the concentration of the indicator.
17. 16. The apparatus according to claim 15, wherein the evaluation unit is further programmed in step f) to determine the blood volume in the tissue from the areas under the inflow function i(t) and the outflow function o(t).
18. The evaluation unit is further programmed to iteratively determine the inflow function i(t) in several steps, where in each step an approximation of the inflow function i(t) is calculated according to the following formula: ##EQU00012## where d / dt(cICG(t)) is the determinable time change of the indicator concentration in the tissue, and o(t) is the efflux function that can be determined from the deconvolution of the convolution integral of the inflow function i(t) and the transport function g(t) by ##EQU00013## 16. The apparatus of claim 15.
19. 16. The apparatus according to claim 15, characterized in that the evaluation unit is further programmed such that the termination criterion for determining the mean transit time mtt is defined by a plausibility criterion of the inflow function i(t) and the outflow function o(t).
20. 20. The apparatus according to claim 19, characterized in that the evaluation unit is further programmed such that the plausibility criterion is definable as a distance between the center of gravity of the inflow function i(t) and the center of gravity of the outflow function o(t) corresponding to the determinable mean transit time mtt.
21. 20. The apparatus according to claim 19, characterized in that the evaluation unit is further programmed such that the plausibility criterion is definable as a ratio of an area under the inflow function i(t) and an area under the outflow function o(t).
Citation Information
Patent Citations
Apparatus for non-invasively determining blood oxygen saturation level within tissue of subject, apparatus for calibrating near infrared spectrophotometric sensor, and apparatus for non-invasively determining oxyhemoglobin concentration and deoxyhemoglobin concentration within tissue of subject
JP2010088928A
Cerebral blood flow measurement method and measurement apparatus
JP2019076460A
Device for measuring the blood flow in an organ
US20040249275A1
Process and device for non-invasively determining cerebral blood flow by near-infrared spectroscopy
US6223069B1
Method for non-invasive spectrophotometric blood oxygenation monitoring
US6456862B2
